Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Vivek K VyasSurmil Shah

Abstract

Ang II-AT1 receptors play an important role in mediating virtually all of the physiological actions of Ang II. Several drugs (SARTANs) are available, which can block the AT1 receptor effectively and lower the blood pressure in the patients with hypertension. Currently, there is no experimental Ang II-AT1 structure available; therefore, in this study we modeled Ang II-AT1 receptor structure using homology modeling followed by identification and characterization of binding sites and thereby assessing druggability of the receptor. Homology models were constructed using MODELLER and I-TASSER server, refined and validated using PROCHECK in which 96.9% of 318 residues were present in the favoured regions of the Ramachandran plots. Various Ang II-AT1 receptor antagonist drugs are available in the market as antihypertensive drug, so we have performed docking study with the binding site prediction algorithms to predict different binding pockets on the modeled proteins. The identification of 3D structures and binding sites for various known drugs will guide us for the structure-based drug design of novel compounds as Ang II-AT1 receptor antagonists for the treatment of hypertension.

References

Jul 15, 1992·Biochemical and Biophysical Research Communications·C A MauzyF Z Chung
Sep 1, 1993·Protein Science : a Publication of the Protein Society·C Colovos, T O Yeates
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
May 2, 2003·Molecular Biotechnology·John E Hall
Jan 25, 2008·BMC Bioinformatics·Yang Zhang
Oct 13, 2010·Mini Reviews in Medicinal Chemistry·V K Vyas, M Ghate
May 9, 2012·Nucleic Acids Research·João P G L M RodriguesGaurav Chopra
Apr 16, 2013·Biochemical and Biophysical Research Communications·Valerio G BaraunaJose E Krieger
Sep 10, 2013·Current Computer-aided Drug Design·Vivek K VyasParesh Patel
Feb 18, 2015·Current Opinion in Pharmacology·Daian Chen, Thomas M Coffman

❮ Previous
Next ❯

Citations

Sep 7, 2018·Chemical Biology & Drug Design·Muhammed Tilahun Muhammed, Esin Aki-Yalcin
Aug 5, 2020·Expert Opinion on Therapeutic Patents·Fenju WeiPeng Zhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.